Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine Maleate
2. 6-(2,5-dichlorophenyl)-2,4-diamino-1,3,5-triazine
3. Dcpdat
4. Irsogladine
5. Mn 1695
6. Mn-1695
1. 84504-69-8
2. Gaslon
3. Mn-1695
4. 57381-28-9
5. Irsogladine (maleate)
6. Irsogladine Maleate [jan]
7. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine Maleate
8. 66gvu60epq
9. 84504-69-8 (maleate)
10. 1,3,5-triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-, (z)-2-butenedioate (1:1)
11. Irsogladine Hbr
12. Dsstox_cid_20234
13. Dsstox_rid_79454
14. Dsstox_gsid_40234
15. Gaslon N
16. Cas-84504-69-8
17. Unii-66gvu60epq
18. Ccris 8107
19. Iosogladine Maleate
20. Ncgc00160397-01
21. Dicloguamine Maleate
22. Gaslon N (tn)
23. Mn 1695
24. Irsogladine Maleate- Bio-x
25. Irsogladine Maleate (jp17)
26. Schembl440934
27. Chembl1712923
28. Dtxsid2040234
29. Irsogladine Maleate [mi]
30. Chebi:31721
31. Hy-b0327a
32. (z)-but-2-enedioic Acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine
33. Hms2051d03
34. Hms2230l23
35. Hms3269m05
36. Hms3413d15
37. Hms3677d15
38. Hms3714e21
39. S-triazine, 2,4-diamino-6-(2,5-dichlorophenyl)-, Maleate
40. Tox21_111786
41. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine; Maleic Acid
42. Irsogladine Maleate [who-dd]
43. Mfcd00873566
44. Akos015961793
45. Tox21_111786_1
46. Ac-6801
47. Ccg-100912
48. Hs-0056
49. Nc00162
50. Ncgc00160397-04
51. Bi164585
52. I0719
53. D01658
54. 504i698
55. A831420
56. A840825
57. Sr-01000763269-4
58. Q27263995
59. 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine Maleate
60. 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazinemaleate
61. 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine Maleat
62. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine Maleate(1:1)
63. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diaminemaleate(1:1)
64. 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine (2z)-but-2-enedioate
Molecular Weight | 372.16 g/mol |
---|---|
Molecular Formula | C13H11Cl2N5O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 3 |
Exact Mass | 371.0188092 g/mol |
Monoisotopic Mass | 371.0188092 g/mol |
Topological Polar Surface Area | 165 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 351 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Radiation-Protective Agents
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?